Answers are grounded in this paper and cite their sources.
Review details the pathogenic mechanisms of ATP synthase deficiency across cardiovascular, neurodegenerative, and metabolic disorders, highlighting tissue-specific vulnerability to energy failure.
Human diseases range from gene-associated to gene-non-associated disorders, including age-related diseases, neurodegenerative, neuromuscular, cardiovascular, diabetic diseases, neurocognitive disorders and cancer. Mitochondria participate to the cascades of pathogenic events leading to the onset and progression of these diseases independently of their association to mutations of genes encoding mitochondrial protein. Under physiological conditions, the mitochondrial ATP synthase provides the most energy of the cell via the oxidative phosphorylation. Alterations of oxidative phosphorylation mainly affect the tissues characterized by a high-energy metabolism, such as nervous, cardiac and skeletal muscle tissues. In this review, we focus on human diseases caused by altered expressions of ATP synthase genes of both mitochondrial and nuclear origin. Moreover, we describe the contribution of ATP synthase to the pathophysiological mechanisms of other human diseases such as cardiovascular, neurodegenerative diseases or neurocognitive disorders.
No takes yet. Share an insight, caveat, or question.
Galber et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: